DR. ROBBIE D SAWYER O.D.
Prescription History 1366447021
Optometrist in Big Stone Gap, VA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ROBBIE D SAWYER O.D., an active Optometrist specialist practicing in Big Stone Gap, VA. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 441 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 276 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other VA PrescribersVs. VA Avg |
|---|---|---|---|
| Latanoprost | 276 | $19.01▼ below VA avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 276 Medicare prescriptions for Latanoprost, about 2 times the volume of the typical Virginia prescriber of this medication (140). Medicare paid an average of $19.01 per fill, versus $21.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 333.8 30-Day Fills standardized to 30-day supplies 8,924 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 29 | $19.08▼ below VA avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 29 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical Virginia prescriber of this medication (77). Medicare paid an average of $19.08 per fill, versus $35.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 53.2 30-Day Fills standardized to 30-day supplies 1,594 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 20 | $62.67 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 20 Medicare prescriptions for Dorzolamide Hcl, about a third of the volume of the typical Virginia prescriber of this medication (56). Medicare paid an average of $62.67 per fill, versus $31.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41.3 30-Day Fills standardized to 30-day supplies 1,240 Days of Medication total across all patients in 2023 | |||
| Azithromycin | 18 | $4.51▼ below VA avg | ▼ Less than typical |
About Azithromycin: This medication is used to treat certain eye infections. Show more ▾ It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2023, this provider wrote 18 Medicare prescriptions for Azithromycin, about half the volume of the typical Virginia prescriber of this medication (34). Medicare paid an average of $4.51 per fill, versus $10.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 18 30-Day Fills standardized to 30-day supplies 90 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 16 | $50.19 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 16 Medicare prescriptions for Ketorolac Tromethamine, about a quarter of the volume of the typical Virginia prescriber of this medication (72). Medicare paid an average of $50.19 per fill, versus $26.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16.7 30-Day Fills standardized to 30-day supplies 397 Days of Medication total across all patients in 2023 | |||
| Travoprost | 16 | $367.39 | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 16 Medicare prescriptions for Travoprost, about half the volume of the typical Virginia prescriber of this medication (30). Medicare paid an average of $367.39 per fill, versus $249.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29.3 30-Day Fills standardized to 30-day supplies 820 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 14 | $67.21 | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 14 Medicare prescriptions for Brimonidine Tartrate, about a quarter of the volume of the typical Virginia prescriber of this medication (66). Medicare paid an average of $67.21 per fill, versus $42.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 795 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 14 | $677.65▼ below VA avg | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 14 Medicare prescriptions for Restasis, about a third of the volume of the typical Virginia prescriber of this medication (37). Medicare paid an average of $677.65 per fill, versus $1,179.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 14 30-Day Fills standardized to 30-day supplies 405 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $425.12 | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 13 Medicare prescriptions for Brimonidine Tartrate-Timolol, about half the volume of the typical Virginia prescriber of this medication (23). Medicare paid an average of $425.12 per fill, versus $287.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.5 30-Day Fills standardized to 30-day supplies 705 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 13 | $14.68▼ below VA avg | ▼ Less than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 13 Medicare prescriptions for Ofloxacin, about 19% of the volume of the typical Virginia prescriber of this medication (69). Medicare paid an average of $14.68 per fill, versus $17.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 13.7 30-Day Fills standardized to 30-day supplies 305 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $14.87 | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 12 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical Virginia prescriber of this medication (39). Medicare paid an average of $14.87 per fill, versus $14.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 257 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ROBBIE D SAWYER O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Big Stone Gap, VA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among VA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
